// App-Quantinova.ai

155 : MHC class I antigen presentation is associated with an inflamed SCLC tumor microenvironment characterized by a higher density of cytotoxic T-cells in closer proximity to tumor cells

Researchers

Presenter

  • Miljenka Vuko

Principal Investigators

  • Mingchao Xie

  • Monica Azqueta Gavaldon

  • Felix Segerer

  • Andreas Spitzmüller

  • Harald Hessel

  • Marco Testori

  • Johannes Zimmermann

  • Michael Surace

  • Mari Heininen-Brown

  • Jaime Rodriguez Canales

  • Shashank Saran

  • Helen Angell

  • Guenter Schmidt

  • Hadassah Sade

  • J Carl Barrett

  • Markus Schick

  • Giulia Fabbri

Medical Centers

  • Astrazeneca, Munich, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Small cell lung cancer

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Proliferation marker protein Ki-67

  • Cluster of differentiation 8A

  • HLA class I histocompatibility antigen B-57

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved